Two Novel Myoviruses from the North of Iraq Reveal Insights into Clostridium difficile Phage Diversity and Biology
Bacteriophages (phages) are increasingly being explored as therapeutic agents to combat bacterial diseases, including Clostridium difficile infections. Therapeutic phages need to be able to efficiently target and kill a wide range of clinically relevant strains. While many phage groups have yet to b...
Main Authors: | Srwa J. Rashid, Jakub Barylski, Katherine R. Hargreaves, Andrew A. Millard, Gurinder K. Vinner, Martha R. J. Clokie |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/8/11/310 |
Similar Items
-
The long and sinuous road to phage-based therapy of Clostridioides difficile infections
by: Andrew A. Umansky, et al.
Published: (2023-08-01) -
‘Get in early’; biofilm and wax moth (Galleria mellonella) models reveal new insights into the therapeutic potential of Clostridium difficile bacteriophages
by: Janet Yakubu Nale, et al.
Published: (2016-08-01) -
Clostridium difficile phages: still difficult?
by: Katherine Rose Hargreaves, et al.
Published: (2014-04-01) -
Diversity, Dynamics and Therapeutic Application of <i>Clostridioides difficile</i> Bacteriophages
by: Janet Y. Nale, et al.
Published: (2022-12-01) -
Phage therapy for Clostridioides difficile infection
by: Kosuke Fujimoto, et al.
Published: (2022-10-01)